UBS Group Increases Cabot (NYSE:CBT) Price Target to $103.00

Cabot (NYSE:CBT) had its price target increased by stock analysts at UBS Group from $100.00 to $103.00 in a research report issued on Tuesday, Benzinga reports. The firm presently has a “neutral” rating on the specialty chemicals company’s stock. UBS Group’s target price would suggest a potential upside of 1.90% from the stock’s current price.

A number of other brokerages also recently weighed in on CBT. StockNews.com downgraded shares of Cabot from a “strong-buy” rating to a “buy” rating in a report on Wednesday, February 14th. Deutsche Bank Aktiengesellschaft cut shares of Cabot from a “buy” rating to a “hold” rating and raised their target price for the stock from $88.00 to $95.00 in a report on Thursday, April 18th. Finally, Mizuho upped their price target on Cabot from $104.00 to $109.00 and gave the company a “buy” rating in a report on Tuesday. Three analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $93.67.

Cabot Stock Up 0.0 %

CBT stock opened at $101.08 on Tuesday. Cabot has a 52 week low of $63.73 and a 52 week high of $103.46. The company has a current ratio of 2.04, a quick ratio of 1.30 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $5.60 billion, a price-to-earnings ratio of 13.13, a price-to-earnings-growth ratio of 1.00 and a beta of 1.27. The firm’s 50-day moving average is $91.52 and its two-hundred day moving average is $82.05.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Monday, May 6th. The specialty chemicals company reported $1.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.66 by $0.12. Cabot had a return on equity of 25.52% and a net margin of 11.24%. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.04 billion. During the same period last year, the company posted $1.33 EPS. The firm’s quarterly revenue was down 1.4% on a year-over-year basis. On average, analysts forecast that Cabot will post 6.58 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Cabot news, EVP Jeff Ji Zhu sold 55,233 shares of the business’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $79.91, for a total transaction of $4,413,669.03. Following the sale, the executive vice president now directly owns 97,201 shares of the company’s stock, valued at approximately $7,767,331.91. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 3.07% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of CBT. EverSource Wealth Advisors LLC grew its stake in Cabot by 143.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 333 shares of the specialty chemicals company’s stock valued at $28,000 after acquiring an additional 196 shares in the last quarter. Arlington Trust Co LLC purchased a new position in Cabot during the fourth quarter valued at approximately $34,000. Hexagon Capital Partners LLC lifted its position in Cabot by 81.8% in the 4th quarter. Hexagon Capital Partners LLC now owns 460 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 207 shares in the last quarter. SRS Capital Advisors Inc. boosted its stake in shares of Cabot by 372.0% during the 4th quarter. SRS Capital Advisors Inc. now owns 505 shares of the specialty chemicals company’s stock valued at $42,000 after buying an additional 398 shares during the period. Finally, GAMMA Investing LLC purchased a new position in shares of Cabot during the 4th quarter valued at $44,000. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.